The U.S. Food and Drug Administration (FDA) has announced a recall of a Medtronic insulin device which could result in diabetes patients getting too much or too little insulin. The Medtronic MiniMed Paradigm Insulin Infusion device could lead to dangerous insulin levels that result in death.
Medtronic has come under fire lately for several of its products, including the Medtronic Infuse Bone Graft device, which is designed to develop bone growth in the spine when inserted through the abdomen. Medtronic allegedly promoted that the device could be inserted through the back, which was not approved by the FDA and could lead to serious complications.
Several patients have filed Infuse lawsuits after discovering the company allegedly promoted the device illegally, leading to an increased risk of side effects. Medtronic Infuse Bone Graft side effects include excessive bone growth, paralysis and retrograde ejaculation.